GlassScriptPhysician profile
Nicole M Gress
NPI 1356590582
$7,723.39
in general payments reported to CMS, 2019-2025
57 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,261 · 2020: $262 · 2021: $427 · 2022: $997 · 2023: $1,084 · 2024: $550 · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,777.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,500.00 | 2019 | |
| Abbvie INC. | $1,086.12 | 2019-2025 | |
| Hologic Sales and Service, LLC | $380.34 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System, Aptima |
| Mayne Pharma Commercial LLC | $351.96 | 2021-2025 | |
| Pfizer INC. | $281.64 | 2019-2025 | |
| Exeltis, USA INC. | $235.72 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $228.12 | 2023-2025 | Veozah |
| Organon LLC | $186.83 | 2024-2025 | Nexplanon, Jada System |
| Gynesonics, INC. | $163.22 | 2022 | |
| Cytyc Surgical Products, LLC | $144.12 | 2023 | Acessa Provu System |
| Aspira Women'S Health INC | $132.66 | 2019-2022 | |
| Millicent US INC | $128.31 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Sumitomo Pharma America, INC. | $105.83 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $104.95 | 2019-2022 | |
| Axonics, INC. | $103.72 | 2022-2023 | Axonics, Bulkamid |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Gress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.